2019 API Nanchang

Release time:2019-12-11 Views:88

Time: Oct.10-Oct.12, 2019

Venue: Nanchang Greenland International Expo Center


With the continuous evaluation of the consistency of generic drugs, the implementation of the policy of joint review and approval of the raw material and auxiliary material package, which has made pharmaceutical companies to independently improve product quality and take responsibility for their own products. It has also greatly improved the subjective initiative of API companies. China's API market will have new vitality with the implementation of the joint review and approval policy. "Traditional and Powerful" producers like Sinopharm, Tianyao Group, Shanghai Pharmaceutical Group, Qilu Pharmaceutical, Northeast Pharmaceutical, Shandong Xinhua, Livzon Group, Huahai Pharmaceutical, Hisun Pharmaceutical, Chuangnuo Pharmaceutical, Hengxin Pharmaceutical, Disha Pharmaceutical and Erkang Pharmaceutical gathered in Nanchang with their traditional superior products and newly developed varieties, together with more than 1,000 outstanding API companies in China, setting booth in Halls A6 and A7. And the theme of this exhibition is "Stay True, Materials Create Future".


NCMC actively participated in the exhibition with pharmaceutical raw materials such as iodide series products, lithium compounds, special esters, amines and nitriles. Even though the economic environment is not optimistic, we had fully exchanged opinions with suppliers and customers to plan for the outlook of pharmaceutical industry and make efforts to better serve the market.


We look forward to meeting with all friends in Qingdao API next year!